Innovent Biologics Inc (IVBIY)
19.48
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Innovent Biologics Debt to Equity Ratio: 0.2811 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.2811 |
| June 30, 2023 | 0.3096 |
| December 31, 2022 | 0.2892 |
| June 30, 2022 | 0.278 |
| December 31, 2021 | 0.2312 |
| June 30, 2021 | 0.1544 |
| December 31, 2020 | 0.1344 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.1466 |
| December 31, 2019 | 0.1735 |
| June 30, 2019 | 0.2273 |
| December 31, 2018 | 0.1888 |
| June 30, 2018 | -0.4429 |
| December 31, 2017 | -0.2625 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1344
Minimum
Dec 2020
0.3096
Maximum
Jun 2023
0.2225
Average
0.2293
Median
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0292 |
| CASI Pharmaceuticals Inc | 0.7819 |
| Zai Lab Ltd | 0.00 |
| I-MAB | 0.0517 |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.910B |
| Total Liabilities (Quarterly) | 1.143B |
| Shareholders Equity (Quarterly) | 1.767B |
| Current Ratio | 3.000 |
| Net Debt Paydown Yield | -0.39% |